Quantinuum (HON): The Quantum Computing Dark Horse with a $300M Backlog and Honeywell Backing

Quantinuum, the quantum computing division of Honeywell (NYSE: HON), is emerging as a formidable player in the quantum race, combining Honeywell’s industrial expertise with a pure-play quantum focus. With a $300 million backlog and a clear path to profitability, Quantinuum offers a unique risk-reward profile for investors seeking exposure to quantum computing without the volatility of pure-play startups.

Thesis

Quantinuum is leveraging Honeywell’s deep R&D capabilities and balance sheet to build a leading trapped-ion quantum computer. The company has a $300 million backlog, indicating strong commercial traction, and is on track to achieve positive EBITDA by 2027. A potential spin-off or IPO could unlock significant value, as Honeywell has signaled its intention to list Quantinuum separately.

12-Month Catalysts

  • Spin-off or IPO announcement: Honeywell has indicated it may spin off Quantinuum, which could unlock value and attract quantum-focused investors.
  • Backlog conversion: The $300 million backlog is expected to convert into revenue over the next 12-18 months, driving a step-change in revenue growth.
  • Product launches: Quantinuum is expected to release its next-generation quantum processor, the H2, which could achieve quantum advantage for specific applications.
  • Partnerships: Collaborations with cloud providers like Microsoft Azure and Amazon Web Services could expand distribution and drive adoption.

Key Risks

  • Spin-off risk: The spin-off may be delayed or structured unfavorably for current Honeywell shareholders.
  • Competition: IonQ, Rigetti, and IBM are also advancing their quantum systems, and Quantinuum may not achieve technological leadership.

Valuation Summary

Quantinuum is valued at approximately $5 billion based on Honeywell’s implied valuation. This is reasonable compared to IonQ’s $7 billion market cap, especially given Quantinuum’s stronger backlog and Honeywell’s backing. A successful spin-off could lead to a rerating to $8-10 billion.

Balance Sheet Summary

Quantinuum benefits from Honeywell’s strong balance sheet, with Honeywell holding over $10 billion in cash and generating robust free cash flow. Quantinuum itself is not yet profitable but has sufficient funding to reach profitability without dilutive capital raises.

Risk Disclaimer: This is not financial advice. Investing in quantum computing stocks involves significant risk, including technological uncertainty, competition, and potential dilution. Do your own research before investing.